Design and synthesis of some novel oxiconazole-like carboacyclic nucleoside analogues, as potential chemotherapeutic agents

Helvetica Chimica Acta

Volumn 92, Issue 9, 2009, Pages 1760-1774

  Rad, Mohammad Navid Soltani ^a   Khalafi Nezhad, Ali ^b   Behrouz, Somayeh ^b  

^a SHIRAZ UNIVERSITY OF TECHNOLOGY   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

2-BROMOACETOPHENONES; CHEMOTHERAPEUTIC AGENTS; GOOD YIELD; HEAT OF FORMATION; IMIDAZOLE DERIVATIVES; NUCLEOBASES; NUCLEOSIDE ANALOGUES; OXIMATION; OXIME ETHERS; SEMI-EMPIRICAL;

ALKYLATION; BIOMOLECULES; ETHERS; PLANTS (BOTANY); SYNTHESIS (CHEMICAL); THERMOCHEMISTRY;

ISOMERS;

1 [2 (HYDROXYIMINO) 2 PHENYLETHYLPYRIMIDINE 2,4(1H,3H) DIONE; 1 PHENYL 2 (2 PHENYL 1H IMIDAZOL 1 YL)ETHANONE; 2 (1H BENZIMIDAZOL 1 YL) 1 (1,1' BIPHENYL 4 YL)ETHANONE; 2 (1H BENZIMIDAZOL 1 YL) 1 (BIPHENYL 4 YL) N HYDROXYETHANIMINE; 2 (1H BENZIMIDAZOL 1 YL) 1 PHENYLETHANONE; 2 (1H BENZIMIDAZOL 1 YL) N (2 PHENOXYETHOXY) 1 PHENYLETHANIMINE; 2 (1H BENZIMIDAZOL 1 YL) N (BENZYLOXY) 1 PHENYLETHANIMINE; 2 (1H BENZIMIDAZOL 1 YL) N HYDROXY 1 PHENYLETHANIMINE; 2 (1H BENZOTRIAZOL 1 YL) 1 PHENYLETHANONE; 2 (1H BENZOTRIAZOL 1 YL) N HYDROXY 1 PHENYLETHANIMINE; 2 (1H IMIDAZOL 1 YL) 1 PHENYLETHANONE; 4 CHROMANONE DERIVATIVE; 7 [2 (HYDROXYIMINO) 2 PHENYLETHYL] 1,3 DIMETHYL 3,7 DIHYDRO 1H PURINE 2,6 DIONE; 9 [2 (HYDROXYIMINO) 2 PHENYLETHYL] 9H PURIN 6 AMINE; ACETOPHENONE DERIVATIVE; ANTIINFECTIVE AGENT; IMIDAZOLE DERIVATIVE; N BENZYL 9 [2 (HYDROXYIMINO) 2 PHENYLETHYL] 9H PURIN 6 AMINE; N HYDROXY 1 PHENYL 2 (2 PHENYL 1H IMIDAZOL 1 YL)ETHANIMINE; N HYDROXY 2 (1H IMIDAZOL 1 YL) 1 PHENYLETHANIMINE; N HYDROXY 2 (2 METHYL 4 NITRO 1H IMIDAZOL 1 YL) 1 PHENYLETHANIMINE; NAFIMIDONE; NUCLEIC ACID BASE; NUCLEOSIDE DERIVATIVE; OXICONAZOLE; PHENACYL BROMIDE; PURINE; PYRIMIDINE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALKYLATION; ARTICLE; DRUG DESIGN; ISOMER; PRIORITY JOURNAL; QUANTUM MECHANICS; SYNTHESIS;

EID: 70349470630     PISSN: 0018019X     EISSN: None     Source Type: Journal    
DOI: 10.1002/hlca.200900051     Document Type: Article

References (55)

1. S. Shadomy, H. J. Shadomy, G. E. Wagner, in 'Antifungal Compounds', Eds. M. R. Siegel, H. D. Sisler, Marcel Dekker, New York 1977, Vol.1, Chapter 1;
2. J. E. Bennett, G. L. Mandell, R. G. Douglas, 'Principles & Practice of Infections Diseases', 3rd edn., Churchill Livingston, New York, 1990, Vol.1.
3. W. W. Turner, M. J. Rodriguez, Curr. Pharm. Des. 1996, 2, 209.
4. G. P. Bodey, Clin. Infect. Dis. 1992, 14, S161.
5. A. Rossello, S. Bertini, A. Lapucci, M. Macchia, A. Martinelli, S. Rapposelli, E. Herreros, B. Macchia, J. Med. Chem. 2002, 45, 4903.
6. R. J. Phillpotts, D. C. Delong, J. Wallace, R. W. Jones, S. E. Reed, D. A. J. Tyrrell, Lancet 1981, 317, 1342;
7. F. G. Hayden, J. M. Gawaltney Jr., Antimicrob. Agents Chemother. 1982, 21, 892;
8. F. D. Miller, A. S. Monto, D. C. DeLong, A. Exelby, E. R. Bryan, S. Srivastava, Antimicrob. Agents Chemother. 1985, 27, 102.
9. A. Kleeman, J. Engel, B. Kutscher, D. Reichert, 'Pharmaceutical Substances', 3rd edn., Thieme, Stuttgart, 1999.
10. J. Kassa, Clin. Toxicol. 2002, 40, 803.
11. K. Sakene, K. Kawabata, Y. Inamoto, H. Yamanaka, T. Takaya, Yakugaku Zasshi 1993, 113, 605.
12. M. N. Mordi, M. D. Petta, V. Boote, G. A. Morris, J. Barber, J. Med. Chem. 2000, 43, 467;
13. J. Gharbi- Benarous, M. Delaforge, C. K. Jankowski, J. P. Girault, J. Med. Chem. 1991, 34, 1117.
14. F. De Clerck, J. Beetens, A. Van de Water, E. Vercammen, P. A. J. Janssen, Thromb. Haemostasis 1989, 61, 43;
15. H. Vanden Bossche, G. Willemsens, D. Bellens, P. A. J. Janssen, Biochem. Pharmacol. 1992, 43, 739.
16. G. Mixich, K. Thiele, Arzneim. Forsch. 1979, 29, 1510;
17. M. Artico, R. Rango, G. C. Porretta, S. Massa, C. Musin, M. G. Spiga, S. Carrias, P. La Colla, Med. Chem. Res. 1996, 137;
18. Y. Wahbi, R. Caujolle, C. Tournaire, M. Payard, M. D. Linas, J. P. Seguela, Eur. J. Med. Chem. 1995, 30, 955.
19. S. Emami, M. Falahati, A. Banifatemi, K. Moshiri, A. Shafiee, Arch. Pharm. 2002, 335, 318;
20. S. Emami, M. Falahati, A. Banifatemi, M. Amanlou, A. Shafiee, Bioorg. Med. Chem. 2004, 12, 3971;
21. S. Emami, M. Falahati, A. Banifatemi, A. Shafiee, Bioorg. Med. Chem. 2004, 12, 5881.
22. A. Karakurt, S. Dalkara, M. Özlap, S. Özbey, E. Kendi, J. P. Stables, Eur. J. Med. Chem. 2001, 36, 421.
23. K. Bhandari, N. Srinivas, G. B. S. Keshava, P. K. Shukla, Eur. J. Med. Chem. 2009, 44, 437.
24. E. De Clercq, in 'Advances in Antiviral Drug Design', Ed. N. G. Johnsson, JAI Press, Greenwich, 1993, Vol.1, p. 88;
25. L. A. Agrofoglio, S. R. Challand, 'Acyclic, Carbocyclic and L-Nucleosides', Kluwer, Dordrecht, 1998;
26. T. Pathak, Chem. Rev. 2002, 102, 1623;
27. L. A. Agrofoglio, I. Gillaizeau, Y. Saito, Chem. Rev. 2003, 103, 1875;
28. D. M. Huryn, M. Okabe, Chem. Rev. 1992, 92, 1745.
29. a) A. Khalafi-Nezhad, M. N. Soltani Rad, A. A. Moosavi-Movahedi, M. Kosari, Helv. Chim. Acta 2007, 90, 730;
30. b) A. Khalafi-Nezhad, M. N. Soltani Rad, A. Khoshnood, Synthesis 2004, 583;
31. c) A. Khalafi-Nezhad, A. Zarea, M. N. Soltani Rad, B. Mokhtari, A. Parhami, Synthesis 2005, 419;
32. d) M. N. Soltani Rad, A. Khalafi-Nezhad, S. Behrouz, M. A. Faghihi, A. Zare, A. Parhami, Tetrahedron 2008, 64, 1778;
33. e) A. Khalafi-Nezhad, M. N. Soltani Rad, G. H. Hakimelahi, B. Mokhtari, Tetrahedron 2002, 58, 10341;
34. f) A. Khalafi-Nezhad, A. Zare, A. Parhami, M. N. Soltani Rad, ARKIVOC 2006, xii, 161.
35. D. Nardi, A. Tajana, A. Leonardi, R. Pennini, F. Portioli, M. J. Magistretti, A. Subissi, J. Med. Chem. 1981, 24, 727;
36. K. Hofmann, 'The Chemistry of Heterocyclic Compounds: Imidazole and its Derivatives', Part 1, Interescience, London, 1953;
37. M. R. Grimmett, in 'Comprehensive Heterocyclic Chemistry II', Eds. A. R. Katritzky, C. W. Rees, E. F. V. Scriven, 1996, Vol.3 (I. Shinkai), p. 77;
38. M. R. Grimmett, Adv. Heterocycl. Chem. 1970, 12, 163;
39. R. Hodges, M. R. Grimmett, Aust. J. Chem. 1968, 21, 1085;
40. M. Häring, Helv. Chim. Acta 1959, 42, 1845;
41. L. J. Mathias, D. Burkett, Tetrahedron Lett. 1979, 20, 4709;
42. Y. Kikugawa, Synthesis 1981, 124;
43. A. Savignac, C. Roques, M. Hinedi, G. Michel, A. Lattes, Eur. J. Med. Chem. 1990, 25, 449.
44. Z.-Z. Liu, H.-C. Chen, S.-L. Cao, R.-T. Li, Synth. Commun. 1993, 23, 2611.
45. M. N. Soltani Rad, S. Behrouz, M. Dianat, Synthesis 2008, 2055.
46. J. Hartung, M. Schwarz, Org. Synth. 2002, 79, 228;
47. J. Hartung, M. Schwarz, Org. Synth., Coll. Vol.2004, 10, 437;
48. J. S. Buck, W. S. Ide, Org. Synth. 1935, 15, 85;
49. J. S. Buck, W. S. Ide, Org. Synth., Coll. Vol.1943, 2, 622.
50. a) R. F. Deorge, 'Wilson and Grisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry', 8th edn., J. B. Lippincott Company, 1982;
51. b) G. Thomas, 'Medicinal Chemistry', 1st edn., John Wiley & Sons Ltd., 2000.
52. A. Khalafi-Nezhad, M. N. Soltani Rad, H. Mohabatkar, Z. Asrari, B. Hemmateenejad, Bioorg. Med. Chem. 2005, 13, 1931;
53. K. Butler, H. L. Howes, J. E. Lynch, D. K. Pirie, J. Med. Chem. 1967, 10, 891.
54. C. K. Chu, S. J. Cutler, J. Heterocycl. Chem. 1986, 23, 289;
55. H. J. Schaeffer, S. Gurwara, R. Vince, S. Bittner, J. Med. Chem. 1971, 14, 367.